Avastin helpful for delaying brain tumor progressionAs per a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance, the usage of Avastin in alone can prove helpful in treating a subgroup of recurrent Grade 3 brain tumors.

It was revealed that this drug is not only safe but also effective in delaying progression.

Avastin, known generically as bevacizumab, is the first approved therapy that is designed for inhibiting angiogenesis.

Chamberlain, director of the Neuro-oncology Program at the SCCA and a professor of neurology and neurological surgery at the University Of Washington School Of Medicine, remarked that bevacizumab has the unique potential of being the most effective form of palliative treatment.